by admin | Apr 19, 2024 | Article
February 14, 2024 – “In the spring of 2022, even as COVID-19 restrictions were being lifted across the country (and the world), there was still a great deal of concern from immunocompromised patients about how they navigate the ‘post-pandemic world’. In response...
by admin | Apr 19, 2024 | Article
On April 14, Evusheld – the only pre-exposure long-acting monoclonal antibody for COVID-19 prevention – was authorized by Health Canada and recently supported with broad recommendations for use in immune-compromised Canadians by the Canadian Agency...
by admin | Apr 19, 2024 | Article
https://www.lupuscanada.org/wp-content/uploads/Immune-Compromised-Canadians-and-COVID-19.pdf
by admin | Apr 19, 2024 | Article
https://www.healthing.ca/diseases-and-conditions/coronavirus/vaccine-for-coronavirus/immunocompromised-living-with-covid
by admin | Apr 19, 2024 | Article
Please note that as the COVID-19 landscape continues to evolve, information is regularly updated and the links may expire and/or be replaced. Alberta• COVID-19 Information for Albertans British Columbia• Latest information on COVID-19 in BC ...
